Bavarian Nordic Deal Opens Up Potential China Market For RSV Vaccine
Company Lags Behind Big Players, But Could Seize Asian Opportunity
As three big players get set to reveal pivotal data for adult RSV vaccines, Bavarian Nordic seals a deal for its candidate that could still claim a sizeable niche if a late-stage trial delivers.
